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Abstract We aimed to evaluate the differences
between exercise testing (ET), myocardial perfusion
SPECT (MPS) and a combination of ET and MPS
based risk assessment as outlined by the guidelines
with respect to their ‘‘gate-keeper’’ role to coronary
angiography (cath) and the associated diagnostic
procedural costs if prognostic considerations, as those
proposed by the current guidelines and the recent
literature, were taken into account. The Duke-score
and the summed difference score (SDS; extent of
ischemia) were assessed in 955 consecutive patients
referred for MPS combined with ET. According to
the guidelines and the available literature, three
different algorithms for risk stratification were retro-
spectively applied: (1) ET based risk stratification
and cath if intermediate or high risk Duke-score; (2)
MPS based risk stratification and cath if SDS C 8; (3)
combined approach with ET as first step and MPS in
case of intermediate risk Duke-score. A cath would
have been suggested in every patient with either high
risk Duke-score or SDS C 8 in patients with inter-
mediate risk Duke-score. The referral rate to cath was
27% according to the ET alone, 13% using MPS, and
finally 12% applying the combined risk stratification.
The cost of the diagnostic work-up including cath
were: 615€, 1’299€, and 598€ per patient, respec-
tively. The coronary angiography referral rate widely
depends on the diagnostic modality used for risk
stratification and according to the referral criteria
provided by the guidelines. In the present study, the
use of a stress imaging modality (MPS) and published
prognostic data was associated with a lower referral
rate to cath as compared to exercise testing alone and
thus underlines the advantage of a risk based
approach applying stress imaging in patients with
intermediate risk Duke-score.
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Introduction
Exercise testing and myocardial perfusion SPECT
(MPS) are well established for the diagnostic and
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prognostic assessment of patients with suspected or
known coronary artery disease (CAD). The results of
both non-invasive diagnostic modalities help to guide
the therapeutic approach and identify candidates for
coronary angiography among patients with stable
CAD. According to the American College of Cardi-
ology/American Heart Association (ACC/AHA)
guidelines, patients with stable CAD stratified to
low risk after exercise testing can be managed
medically without need of coronary angiography
and patients at high risk should be referred for
coronary angiography. For patients with intermediate
risk according to exercise testing, the guidelines
suggest either a coronary angiography or an exercise
imaging test [1]. Even if MPS is considered superior
to exercise testing for risk stratification of patients
with CAD, to date there is no direct comparison
between these diagnostic modalities with respect to
the their ‘‘gate-keeper’’ role for coronary angiography
if indications as outlined by the available guidelines
and the prognostic literature are applied [2–6]. In this
context, and considering that the guidelines advise
either direct coronary angiography or supplementary
imaging based risk stratification for patients with
intermediate risk Duke-score, we aimed to compare
the hypothetical referral rate to coronary angiography
based on three different risk stratification algorithms:
(a) risk stratification based on exercise testing alone,
(b) risk stratification based on MPS alone, and (c) risk
stratification based on combined diagnostic modali-
ties with exercise testing as first line assessment and
subsequent MPS for patients with intermediate risk
according to exercise testing. Furthermore we aimed
to compare the costs of the above described diagnos-
tic approaches.
Materials and methods
Patient population
Consecutive patients referred for MPS for CAD
evaluation (n = 1,132) who were able to undergo
exercise stress (bicycle ergometry) were included in
this analysis. Patients with ST-segment depression
C1 mm or left bundle branch block on their baseline
electrocardiogram were excluded (n = 177). Detailed
medical history has been collected in all patients.
Whenever possible, beta-blocking medications as
well as negative chronotropic calcium antagonists
were withheld for 48 h and long-acting nitrates for
24 h before exercise testing.
Exercise testing
Resting heart rate, blood pressure and 12-lead ECG
were recorded before exercise. A standardized, step-
wise and symptom limited bicycle exercise test was
performed in all subjects to the end points as defined in
the exercise testing guidelines [7]. A 12-lead ECG was
continuously recorded during exercise and recovery.
Blood pressure was recorded every minute during
exercise and recovery. ST-segment deviation was
assessed automatically (CARDIOVIT CS-200, Schil-
ler) and visually controlled and interpreted by an
experienced cardiologist, who was blinded for the MPS
results. Maximum ST-segment depression (STD in
mm, 1 mm = 0.1 mV) was defined as the maximal
exercise-induced ST-segment depression 80 ms after
the J point, which was horizontal or downsloping;
it was calculated by subtracting the maximum
ST-segment deviation during exercise or post exercise
from the resting ST-segment level in the corresponding
lead. Maximum STD was considered ischemic if
C1 mm. Exercise testing was considered positive in
case of typical exercise induced angina or significant
STD (horizontal or downsloping and C1 mm). The
workload was expressed in metabolic equivalents
(METs). Based on the exercise testing variables a
modified Duke-score for bicycle ergometry was
calculated using the following definition: (exercise
capacity in METs-[5 9 maximum ST-segment depres-
sion in mm]-[4 9 angina index]) with angina index
defined as a value of 0 if no angina occurred, 1 if typical
non-test limiting angina, and 2 if test limiting angina
occurred [8, 9]. According to previous published data and
to the ACC/AHA guidelines for patients with chronic
stable angina, patients were stratified in a low risk group if
the Duke-score was C5, intermediate between -10 and 4,
and a high risk B-11 [1, 9].
Myocardial perfusion imaging
All patients underwent routine rest/stress (ergometry)
dual isotope (Tl-201 rest/Tc-99 m sestamibi) MPS
protocol as previously described [10, 11]. Rest-SPECT
was obtained after administration of 111 MBq Tl-201.
Tl-201 SPECT was performed 10 min after tracer
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injection. At near-maximal exercise, a 740 MBq dose
of Tc-99 m sestamibi was injected and exercise was
continued for at least an additional minute after
injection. Post-stress gated SPECT was acquired in
average 95–100 min post-stress. SPECT imaging was
performed following standard protocols. No attenua-
tion or scatter correction was used. SPECT images
were acquired and processed as previously described,
with a circular 1800 acquisition. During imaging, two
energy windows were used for Tl-201, including a
30% window centered on the 70-keV peak and a 20%
window centered on the 167-keV peak. For Tc-99 m
sestamibi SPECT, a 15% window centered on the 140-
keV peak was used.
Semiquantitative visual interpretation was per-
formed using a 20-segment model. Each segment was
scored using a five-point scoring system: 0 = normal,
1 = equivocal, 2 = moderate, 3 = severe reduction
of radioisotope uptake, and 4 = apparent absence of
detectable tracer uptake in a segment. A summed
stress score (SSS) was calculated by adding the
scores of the 20 segments of the stress images, and a
summed rest score (SRS) by adding the scores of the
20 segments of the rest images. To assess defect
reversibility, a summed difference score (SDS) was
calculated by subtracting SRS from SSS, reflecting
the severity and extent of ischemia. MPS was
considered abnormal in case of scar (SRS C 4) or
ischemia (SDS C 2). Moderate to severe ischemia
was defined as an SDS C 8.
Risk stratification according to exercise test,
myocardial perfusion SPECT and combined
approach. Study algorithm for referral to coronary
angiography
According to the available literature and to the
guidelines three different algorithms were defined
based on prognostic information derived from the
exercise test and MPS to refer patients for coronary
angiography (see Table 1) [1, 12–16]. Each of the
described algorithms for risk stratification has been
retrospectively applied to all 955 patients to assess the
hypothetical referral rate to coronary angiography.
Cost analysis
The costs generated by the different diagnostic
procedures were calculated based on the official
Swiss medical system TARMED. The cost estimates
were as follows: coronary angiography 1810 €,
myocardial perfusion SPECT 1060 € and exercise
test 130 €. The cost per patient generated by the
exercise test based risk stratification was calculated
adding the cost of the exercise tests for all patients
and the cost of the coronary angiography for
patients with intermediate to high risk exercise test
results divided by the total number of patients
included in the present analysis. In analogy, the cost
per patient generated by MPS based risk stratifica-
tion was calculated adding the cost of an MPS for
all patients and the cost of coronary angiography for
patients with a SDS C8 divided by the total number
of patients. Finally, the cost per patient generated by
the combined approach for risk stratification was
calculated by summing up the cost of the exercise
test for all patients, the cost of the MPS for patients
with intermediate Duke-score and the cost of the
coronary angiography for patients who qualified for
a further invasive diagnostic procedure as described
in the methods, divided by the total number of
patients.
Statistics
Numerical data are presented as mean ± SD. Cate-
gorical data are presented as numbers and percent-
ages. The different hypothetical referral rates to
coronary angiography of the exercise testing, MPS
and the combined approach were compared with a
Chi-square test. Univariate predictors for discrepant
findings between exercise testing and MPS results
with respect to risk stratification were tested by
Fisher’s test for nominal variables, Students t-test for
numerical variables with equal distribution and
Mann–Whitney test for numerical variables with
non-equally distribution. Independent predictors of
discrepant findings of exercise testing and MPS
results with respect to risk stratification were identi-
fied including the univariate significant variables
(P B 0.05) in a multivariable logistic regression. The
differences between the diagnostic procedural costs
of the different strategies for risk assessment were
compared by the Wilcoxon test. A P-value of B0.05
was considered statistically significant. Analyses
were performed using the commercially available
statistical package SPSS version 15.0.
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Results
Patient characteristics
Patient characteristics are summarized in Table 2.
The mean age of the 955 patients was almost
61 years and the majority were male (70%). Approx-
imately half of the patients had a history of prior
CAD.
Results of stress ECG and myocardial perfusion
SPECT
As shown in Table 3, the majority of patients
achieved the submaximal predicted heart rate and
the maximal double product (peak heart rate x
maximal systolic blood pressure) was consistent with
an adequate stress test. Stress ECG was positive in
266 patients (28%). Among those, 10 patients (4%)
had a low risk, 230 (86%) had an intermediate risk
and 26 (10%) had a high risk.
Myocardial perfusion SPECT was considered
abnormal in almost half of the patients (scar,
ischemia, or both). Among patients with evidence
of ischemia (n = 367, 38%) 126 (13% of the entire
collective) had a SDS C8, consistent with a prog-
nostic high risk ischemia, likely to benefit from
revascularization (Table 4).
Impact of the different algorithms for risk
stratification on referral to coronary angiography
and procedural costs
As depicted in Table 5, applying the exercise testing
based algorithm for risk stratification, 256 patients
(27%) would have been referred to coronary angiog-
raphy because of a positive exercise test and a Duke-
score \5. Using MPS as a first line and only
diagnostic modality for risk stratification, 126
patients (13%) would have been referred to coronary
angiography because of SDS C8. Finally, applying
the algorithm with exercise testing as first tool for
risk stratification with subsequent MPS in case of
intermediate risk exercise testing 112 patients (12%)
would have been referred to coronary angiography;
26 because of a high risk Duke-score and 86 because
of an intermediate risk Duke-score with SDS C8. The
cost per patient of the diagnostic procedure generated
by the three different algorithms were: 615€, 1’299€,
Table 1 Prognostic criteria for referral to coronary angiography according to the 3 different diagnostic and risk stratification
approaches
Exercise testing MPS Combination of exercise testing and MPS
Positive ET with intermediate to high risk Duke-score SDS C 8 Positive ET and high risk Duke-score
Positive ET, intermediate risk Duke-score and SDS C 8
ET exercise testing, SDS summed difference score
Table 2 Baseline characteristics
Overall (n = 955)
Male gender (%) 666 (70)
Age (years ± SD) 61 ± 11
BMI (kg/m2 ± SD) 27.5 ± 4.6
Known CAD (%) 409 (43)
Prior MI (%) 249 (26)
Prior revascularization (%) 377 (40)
Symptoms
Typical angina (%) 219 (23)
Atypical angina (%) 304 (32)
Dyspnoea (%) 321 (34)
Risk factors
Diabetes (%) 222 (23)
Hypercholesterolemia (%) 559 (59)
Hypertension (%) 605 (63)
Family history (%) 303 (32)
Smoking (%) 424 (44)
Medication
Aspirin (%) 653 (68)
b-blockers (%) 540 (57)
Nitrates (%) 66 (7)
Ca-antagonist (%) 154 (16)
ACE-inhibitors (%) 226 (24)
ATII-antagonist (%) 219 (23)
Statins (%) 522 (55)
BMI body mass index, CAD coronary artery disease, MI
myocardial infarction, ACE angiotensin converting enzyme,
ATII angiotensin II
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and 598€ for exercise testing only, MPS, and the
combined approach, respectively (Table 5).
In a subgroup analysis, patients without history of
CAD were evaluated (n = 546, 57%). Of these, 124
(23%) had a positive exercise test and 116 (21%)
would have been referred to coronary angiography
according to the exercise testing based risk stratifi-
cation (Duke-score \ 5). Myocardial perfusion
SPECT was abnormal in 153 patients (28%), 132
(24%) had myocardial ischemia (SDS C 2) and 58
patients (11%) would have been referred to coronary
angiography based on the MPS risk stratification
(SDS C 8). Finally, applying the combined diagnos-
tic approach for risk stratification, 56 (10%) patients
would have been referred to coronary angiography;
15 because of a high risk exercise test and 41 because
of an intermediate risk exercise test with SDS C8
(Table 5).
Correlation between exercise testing
and myocardial perfusion results
The correlation between Duke-score and extent of
ischemia is shown in Fig. 1. As illustrated, the
proportion of patients with greater extent of ischemia
increased as a function of the Duke-score (P-for
trend \ 0.01). Of note, among the 699 (73%) patients
with negative exercise test or positive exercise test
but low risk Duke-score only 18 patients (2.6%) and
1.8% of the entire collective had a SDS C8. Among
patients with a positive exercise test and intermediate
risk Duke-score 38% had a SDS C8. And finally,
among patients with high risk Duke-score 81% had a
SDS C8 (see Fig. 1).
In a univariate analysis, patients with intermediate
or high risk based on exercise testing but SDS\8 on
MPS (58%) more often were female (22 vs. 13%;
P = 0.04), were younger (62.4 ± 9.2 vs.
65.0 ± 10.5 years; P = 0.05), more often had
stopped beta-blockers before exercise testing (60 vs.
42%; P \ 0.01), had achieved a higher peak heart
rate during exercise (147 ± 15 vs. 140 ± 17 beat/
minute; P \ 0.01) and were less likely to have a
history of typical angina (38 vs. 60%; P \ 0.01). In
the multivariate regression analysis, female sex (95%
CI: 1.1–4.3; P = 0.04), discontinuation of beta-
blockers before exercise testing (95% CI: 1.2–3.5;
P \ 0.01), as well as absence of typical angina (95%
CI: 1.5–4.3; P \ 0.01) were independent predictors
of SDS \8 despite of a Duke-score \5.
Discussion
To our knowledge this study is the first one evalu-
ating different diagnostic CAD algorithms based on
the most recent risk stratification data and comparing
the costs of these different approaches [12, 17]. The
present study suggests that the risk stratification of
patients evaluated for known or suspected CAD may
substantially differ depending on the diagnostic
Table 3 Exercise testing variables
Overall (n = 955)
Heart rate
Resting HR (bpm ± SD) 80 ± 15
Peak HR (bpm ± SD) 148 ± 16
Blood pressure
Resting SBP (mmHg ± SD) 129 ± 24
Peak SBP (mmHg ± SD) 213 ± 35
Resting DBP (mmHg ± SD) 81 ± 13
Peak DBP (mmHg ± SD) 79 ± 21
Maximal workload (METs ± SD) 7.2 ± 1.8
Exercise test duration (minutes ± SD) 6 ± 1
Submaximal predicted HR achieved (%) 908 (95)
Double product reached (±SD) 31,590 ± 6,417
Typical angina during exercise (%) 126 (13)
STD C 1 mm (%) 215 (22)
Positive stress ECG (%) 266 (28)
HR heart rate, bpm beats pro minute, SBP systolic blood
pressure, DBP diastolic blood pressure, MET metabolic
equivalent, STD maximal ST-segment depression
Table 4 Results of the myocardial perfusion SPECT
Overall (n = 955)
Scar: SRS C 4 (%) 274 (29)
Ischemia: SDS C 2 (%) 367 (38)
Severe ischemia: SDS C 8 (%) 126 (13)
Abnormal MPS (%) 453 (47)
SRS (median, IQR) 0 (0–4)
SSS (median, IQR) 2 (0–9)
SDS (median, IQR) 0 (0–4)
SRS summed rest score, SDS summed difference score, MPS
myocardial perfusion SPECT, abnormal MPS MPS consistent
with scar or ischemia, IQR interquartile range
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modality used for risk stratification. In this context,
MPS based risk stratification, as well as the combined
approach with exercise testing as first approach and
MPS in case of intermediate risk, may have both a
stronger ‘‘gate-keeper’’ role with respect to referral to
coronary angiography as compared to exercise testing
alone if prognostic considerations of current guide-
lines and the recent literature are taken into account.
Based on the proposed prognostic decisional algo-
rithm, the number of coronary angiographies would
have been reduced by more than 50% using MPS or
the combined approach for risk stratification. Nota-
bly, the lower coronary angiography referral rate was
similar in patients with and without history of CAD.
Of note, the total costs of the diagnostic procedure
were substantially higher if MPS was used in
all patients as a first line modality for risk stratifica-
tion. On the other hand, the combined approach
with stress imaging applied only in selected patients
with intermediate risk during exercise testing
demonstrated a very low risk of misclassification
(meaning that only a minority of patients with low
risk Duke-score had a relevant myocardial ischemia),
and a good cost performance if only costs related to
the diagnostic work-up are considered.
There is plenty of evidence, that imaging modal-
ities, as MPS, provide incremental prognostic value
with respect to prediction of major cardiovascular
events as compared to exercise testing alone. These
findings have been confirmed by several studies and
in different subsets of patients evaluated for known or
suspected CAD [2–6]. Even though, the different
impact of imaging based risk stratification as com-
pared to exercise testing with respect to clinical
decision making and referral to subsequent coronary
angiography has not been analyzed by all of the
above mentioned studies.
The prognostic benefit of revascularization proce-
dures in patients with stable CAD has been questioned
by several recent randomized trials [18–23]. The
recently published COURAGE and BARI 2D studies
showed that percutaneous coronary intervention in
addition to optimal medical treatment was not superior
to medical therapy alone in terms of prognosis and
quality of life [18, 19, 24]. Of note, a documented
ischemia was an inclusion criterion of the COURAGE
trial, but no minimal threshold of myocardium ische-
mic was taken into account for inclusion and patients
with severe ischemia were excluded [18]. This aspect
is of particular importance considering that the benefit
of a revascularization procedure may be dependent on
the extent of ischemic myocardium. A study reported
by Hachamovitch et al. suggested that myocardial
revascularization compared to medical therapy had
greater survival benefit only in patients with moderate
to large amount of inducible ischemia ([10% myo-
cardium ischemic) [12]. This seems to hold true also
Table 5 Referral rates to coronary angiography and procedural costs associated with the different diagnostic and risk stratification
approaches
All patients (n = 955) ET MPS P-value* ET and MPS P-value**
Patients referred to coronary angiography (%) 256 (27) 126 (13) \0.01 112 (12) \0.01
Costs of the diagnostic procedure (per patient, €) 615 1299 \0.01 598 0.02
Patients without known CAD (n = 546)
Patients referred to coronary angiography (%) 116 (21) 58 (11) \0.01 56 (10) \0.01
Costs of the diagnostic procedure (per patient, €) 515 1252 \0.01 512 0.08
ET exercise test, MPS myocardial perfusion SPECT, € Euro, P-value* comparison between MPS and ET, P-value** comparison
between combination of ET/MPS and ET alone
Fig. 1 Interrelation between Duke-score and SDS categories
(P-for trend \ 0.01). Note the relevant proportion of patients
with moderate to severe ischemia among patients with high
risk Duke-score and the low percentage of patients with
moderate to severe ischemia among patients with low risk
Duke-score
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for asymptomatic patients [14]. Similarly, the nuclear
substudy of the COURAGE trial indicates that patients
with moderate to severe pre-treatment ischemia had a
worse prognosis and were more likely to benefit from
revascularization in terms of reduction of myocardium
ischemic and increased event free survival as com-
pared to patients with less severe ischemia [13]. In this
context, the value of non-invasive risk stratification for
patients with stable CAD seems to be of outstanding
importance, in order to select and identify low risk
patients, who can safely be treated medically without
further testing and on the other hand high risk patients,
who may benefit from angiography and potential
revascularization [25].
The present study provides the evidence that
patients’ allocation to a specific risk category may
widely differ according to the diagnostic modality
used for risk assessment. As a consequence, perform-
ing risk stratification with MPS or combination of
exercise testing and MPS on an individual basis result
in less patients being referred to coronary angiogra-
phy as compared to exercise testing alone. Addition-
ally, the costs of the diagnostic procedure were
almost the same if exercise testing alone or the more
‘‘sophisticated’’ combined risk stratification approach
was used. This was due to the reduced number of
coronary angiographies in the combined scenario.
Therefore, the present study underlines possible
advantages of a combined approach with stress
imaging applied in patients with an intermediate risk
exercise test even applying prognostic considerations.
Of note, also considering the results of risk stratifi-
cation the proportion of patients with high risk MPS
results was very low (2.6%) among patients with a
Duke-score indicating a low risk and on the other
hand high (81%) among patients with a high risk
Duke-score. Therefore, among patients stratified to
low or high risk according to the exercise testing
alone, there was a good concordance between exer-
cise testing and MPS with respect to the hypothetical
treatment allocation (medically vs. coronary angiog-
raphy). In contrast, among patients with intermediate
Duke-score a great proportion of patients (62%) did
not meet high-risk criteria on MPS. Patients of female
gender, as well as patients who discontinued beta-
blocking medications before exercise testing or
patients without typical angina were particularly
prone to have discordant results with respect to risk
stratification between exercise testing and MPS,
meaning low risk MPS findings despite of interme-
diate to high risk exercise testing. Keeping in mind,
that MPS is superior to exercise testing for risk
stratification, the present results suggest that further
risk stratification based on MPS in patients with an
intermediate exercise testing Duke-score may be
favorable, in order to reduce the referral rate to
coronary angiography if strictly prognostic consider-
ations, as those proposed by the current guidelines
and the recent literature, are taken into account. Still,
this study is not intended to provide any definitive
advice regarding procedure for risk stratification of
patients evaluated for CAD, but may point to the
relevant differences in risk stratification depending of
the diagnostic modality used.
Limitations
The study is an observational study, no randomized
allocation to different diagnostic procedures for risk
stratification was performed and no follow-up data
were available. The accepted gold standard of
coronary angiography can’t be provided in this study.
Coronary angiography is superior to MPS to establish
the diagnosis of CAD, even though, the combination
of clinical data and myocardial perfusion data has
been shown to be superior than the combination of
clinical data and coronary angiography data for
prognostic purposes [26]. Indeed, even when angio-
graphic CAD is present, MPS is a powerful method
for risk stratification. In this context, as the proposed
decisional algorithm is based strictly on prognostic
consideration, the absence of the angiographic data
should not compromise the conclusion of the present
study. Of course, this data only applies to patients
who are able to undergo an adequate ergometry test
(i.e. this data can’t be used for pharmacologically
stressed patients).
Conclusion
The patients’ allocation to specific risk categories and
the referral rate to coronary angiography may be
widely different depending on the diagnostic modal-
ity used for risk stratification as outlined by the
guidelines. In the present study population, the use of
a stress imaging modality as MPS was associated
with a lower referral rate to coronary angiography as
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compared to exercise testing alone if prognostic
information, as those proposed by the current guide-
lines and the recent literature, were considered. The
present study indicates possible advantages of a
combined approach with individually tailored use of
stress imaging in patients with intermediate risk
exercise tests due to a very low risk of a prognostic
misclassifications for patients with low Duke-score
(meaning that only a minority of patients with low
risk Duke-score had a relevant myocardial ischemia),
and to its good cost performance.
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